Nevan Krogan is the founder of Rezo Therapeutics. Rezo Therapeutics has raised $78M in total funding. Latest round: Series A.
Nevan Krogan is the Founder and President of Rezo Therapeutics, a biotechnology company focused on integrated disease network mapping for precision therapeutics. He co-founded the company with other prominent UCSF researchers. Krogan's expertise lies in team science, systems biology, and disease networks.
Full founder directory · Investor directory · Company funding database · Fundraising library